|
Volumn 333, Issue 7581, 2006, Pages 1234-
|
Measles in developing countries
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIBIOTIC AGENT;
COTRIMOXAZOLE;
MEASLES VACCINE;
RETINOL;
ADENOVIRUS;
ANTIBIOTIC PROPHYLAXIS;
BACTERIAL INFECTION;
CLINICAL FEATURE;
CLINICAL TRIAL;
CONJUNCTIVITIS;
CONTROLLED CLINICAL TRIAL;
COST EFFECTIVENESS ANALYSIS;
DEVELOPING COUNTRY;
EDITORIAL;
HERPES SIMPLEX VIRUS;
HUMAN;
IMMUNIZATION;
MEASLES;
MEASLES VIRUS;
PNEUMONIA;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
SOCIOECONOMICS;
VACCINATION;
VIRUS TRANSMISSION;
WORLD HEALTH ORGANIZATION;
ANTI-BACTERIAL AGENTS;
DEVELOPING COUNTRIES;
HUMANS;
MEASLES;
MEASLES VACCINE;
VITAMIN A;
|
EID: 33846014704
PISSN: 09598146
EISSN: None
Source Type: Journal
DOI: 10.1136/bmj.39058.361620.BE Document Type: Editorial |
Times cited : (12)
|
References (7)
|